IDH1 and neoplasm: While some series show an association between tumor grade and outcome others fail to do so, and many patients with a grade 3 IDH-mutant astrocytoma or IDH-mutant and 1p/19q codeleted oligodendroglioma experience a survival well beyond 10 years.